AdvaMed Dx welcomes Siemens Healthcare Diagnostics as association's newest member

CEO Donal Quinn to Join AdvaMed Dx Board of Directors

AdvaMed Dx, a division of the Advanced Medical Technology Association (AdvaMed) focused on topics affecting the in vitro diagnostics industry, is pleased to welcome Siemens Healthcare Diagnostics as the association's newest member. Donal Quinn, chief executive officer of Siemens Healthcare Diagnostics, has been appointed to the AdvaMed Dx Board of Directors.

"We are delighted to welcome Siemens as the newest member of AdvaMed Dx," said Stephen J. Ubl, president and chief executive officer of AdvaMed. "This is a critical time for the industry, with health reform behind us and implementation ahead.  Now more than ever, there are significant opportunities to promote public policies that will ensure patient access to life-enhancing blood tests and continued innovation in this critical area of medical diagnosis, monitoring and treatment.  Siemens' addition to AdvaMed Dx and its board will aid us in that effort," said Ubl.

"Siemens is pleased to work with AdvaMed Dx to help healthcare providers around the world improve the quality, efficiency and accessibility of healthcare," said Quinn. "We believe AdvaMed Dx is strongly positioned to engage on the important issues impacting the clinical diagnostics industry today."